Search Results 691-700 of 18156 for Hepatitis b

  1. Hugo Botha, M.B., Ch.B. - Doctors and Medical Staff - Mayo Clinic

    2019. FellowshipClinician-Investigator Training Program, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine · 2017. FellowRST Behavioral ...

  2. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Known active hepatitis B or C, or human immunodeficiency virus (HIV) infection; Subjects who, in the opinion of the Investigator, are unable or unlikely to ...

  3. Study of BMF-219, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    ... B-cell Lymphoma (DLBCL), Multiple Myeloma (MM) ... - Known positive test for human immunodeficiency virus, hepatitis C, or hepatitis B surface antigen.

  4. A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders - Mayo Clinic

    Eculizumab. History of Hepatitis B and/or Hepatitis C (Hep B/C at screening); Known history of a primary immunodeficiency (congenital or acquired) or an ...

  5. Efineptakin alfa (NT-I7) Plus Pembrolizumab for the Treatment of Recurrent Glioblastoma - Mayo Clinic

    * Concurrent known active Hepatitis B (i.e., known positive hepatitis B virus \[HBV\] surface antigen \[HBsAg\] reactive) AND known active Hepatitis C (i.e. ...

  6. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma - Mayo Clinic

    Participants with a positive total hepatitis (Hep) B core antibody and negative hepatitis B virus surface antigen (HBsAg) at screening are at high risk for ...

  7. Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies - Mayo Clinic

    hepatitis B DNA testing is negative and the patient is receiving hepatitis B reactivation prophylaxis with entecavir, tenofovir, or lamivudine. Patient is ...

  8. A Study of the Effectiveness and Safety of CTL019 in Adult Patients with Diffuse Large B-Cell Lymphoma - Mayo Clinic

    ... B-Cell Lymphoma. Print details. Share; Facebook ... Active replication of or prior infection with hepatitis B or active hepatitis C( HCV RNA positive ) ...

  9. A Study to Evaluate the Safety, Tolerability, and Determine the Optimal Dose for the Expansion Cohorts of VSV-IFNβ-NIS in Combination with Pembrolizumab in Patients with Refractory Solid Tumors - Mayo Clinic

    Acute hepatitis B or acute hepatitis C. Patients with chronic hepatitis B or hepatitis C may be enrolled provided their liver function is adequate as per ...

  10. Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) - Mayo Clinic

    Tests positive for HBs antibody or hepatitis B virus core protein antibody and has a result of at least detectable in a hepatitis B virus deoxyribonucleic ...